Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prolactin and FGF21 in Gestational Diabetes Mellitus

NCT05528393 is registered in ClinicalTrials.gov with Shen Qu as lead sponsor.

NCT NCT05528393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05528393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prolactin and FGF21 in Gestational Diabetes Mellitus
Lead sponsor
Shen Qu
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2017
Completion date
December 1, 2022
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gestational diabetes mellitus in pregnancy, hyperprolactinemia pregnancy